Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for urinary obstruction symptoms in women
IRCT20230501058042N1Phase 2Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tamsulosin in bladder outlet obstruction (BOO), sponsored by Sabzevar University of Medical Sciences. Primary endpoints: IPSS questionnaire score, Uroflowmetry results and 1 more. Started May 2023; status: completed.
02
Drugs
tamsulosin
03
Conditions
bladder outlet obstruction (BOO)
Beyond the preview
Go deeper on IRCT20230501058042N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230501058042N1.